How Do We Overcome Endocrine Therapy Resistance in Breast Cancers?
Guest Post by Virginia Kaklamani, MD, DSc Co-director of the San Antonio Breast Cancer Symposium (SABCS)
Tag: Clinical trials
Guest Post by Virginia Kaklamani, MD, DSc Co-director of the San Antonio Breast Cancer Symposium (SABCS)
Guest post by L. Michelle Bennett, director of the NCI Center for Research Strategies; Worta McCaskill-Stevens, MD, chief of...
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...
Guest Post by Kelvin Lee, MD Roswell Park Cancer Institute
Guest Post by Barbara A. Conley, MD National Cancer Institute (NCI)
AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
Game-changing modern cancer therapies—immunotherapies and targeted therapies, among others—have been providing promising treatment outcomes in the recent years. The...
Guest Post by Toni Kay Mangskau Mayo Clinic Cancer Center
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...